Smoking and Risk of Incident End-stage Kidney Disease in General Population: A Nationwide Population-based Cohort Study from Korea

Overview

Journal Sci Rep

Specialty Science

Date 2019 Dec 22

PMID 31862942

Citations 15

Authors

Hong Sang Choi

Kyung-Do Han

Tae Ryom Oh

Chang Seong Kim

Eun Hui Bae

Seong Kwon Ma

Soo Wan Kim

Affiliations

Soon will be listed here.

Abstract

We analyzed data from the Korean National Health Insurance Service (NHIS) to investigate whether smoking increases the risk of end-stage kidney disease (ESKD). This retrospective nationwide population-based cohort study included the data of 23,232,091 participants who underwent at least one health examination between 2009 and 2012. Smoking status was recorded at baseline. The incidence of ESKD was identified via ICD-10 codes and special medical aid codes from the Korean National Health Insurance Service database till December 2016. A Cox proportional-hazards model with multivariable adjustment was used to evaluate the association between smoking and ESKD incidence. Overall, 24.6% of participants were current smokers; 13.5% and 61.9%, were ex- and non-smokers, respectively. Overall, 45,143 cases of ESKD developed during the follow-up period. Current smokers (hazard ratio [HR], 1.39; 95% confidence interval [CI], 1.35-1.43) and ex-smokers (HR, 1.09; 95% CI, 1.06-1.12) demonstrated a significant increase in the adjusted risk of ESKD compared to non-smokers. The risk of ESKD was directly proportional to the smoking duration, number of cigarettes smoked daily, and pack-years. In conclusion, smoking is associated with a greater risk of ESKD in the general Korean population; the risk increases with an increase in the smoking duration, number of cigarettes smoked daily, and pack-years.

Citing Articles

Homelessness and Risk of End-Stage Kidney Disease and Death in Veterans With Chronic Kidney Disease.

Koyama A, Nee R, Yu W, Choudhury D, Heng F, Cheung A JAMA Netw Open. 2024; 7(9):e2431973.

PMID: 39254978 PMC: 11388027. DOI: 10.1001/jamanetworkopen.2024.31973.

Approximation of Glomerular Filtration Rate after 1 Year Using Annual Medical Examination Data.

Hirai K, Kitano T, Nakayama K, Morita F, Satomura H, Tanaka T J Clin Med. 2024; 13(14).

PMID: 39064247 PMC: 11278328. DOI: 10.3390/jcm13144207.

Active smoking in urban households: An association between urinary cotinine metabolite level and serum eGFR concentration.

Kunno J, Luangwilai T, Pimviriyakul P, Sematong S, Supawattanabodee B, Kuratong S Tob Induc Dis. 2024; 22.

PMID: 38586496 PMC: 10996036. DOI: 10.18332/tid/186071.

Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study.

Kwon O, Han K, Park M RMD Open. 2023; 9(4).

PMID: 37945288 PMC: 10649888. DOI: 10.1136/rmdopen-2023-003490.

The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects-A Review of Literature.

Surowka A, Prowans P, Zolnierczuk M, Miskiewicz M, Wawrowski T, Skodda M Int J Mol Sci. 2023; 24(12).

PMID: 37373446 PMC: 10299316. DOI: 10.3390/ijms241210291.

References

Hallan S, Orth S . Smoking is a risk factor in the progression to kidney failure. Kidney Int. 2011; 80(5):516-23. DOI: 10.1038/ki.2011.157. View

Doll R, Peto R, Boreham J, Sutherland I . Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004; 328(7455):1519. PMC: 437139. DOI: 10.1136/bmj.38142.554479.AE. View

Lipworth L, Mumma M, Cavanaugh K, Edwards T, Ikizler T, Tarone R . Incidence and predictors of end stage renal disease among low-income blacks and whites. PLoS One. 2012; 7(10):e48407. PMC: 3480508. DOI: 10.1371/journal.pone.0048407. View

Stengel B, Tarver-Carr M, Powe N, Eberhardt M, Brancati F . Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003; 14(4):479-87. DOI: 10.1097/01.EDE.0000071413.55296.c4. View

Haroun M, Jaar B, Hoffman S, Comstock G, Klag M, Coresh J . Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003; 14(11):2934-41. DOI: 10.1097/01.asn.0000095249.99803.85. View

Lan X, Lederman R, Eng J, Marashi Shoshtari S, Saleem M, Malhotra A . Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress. PLoS One. 2016; 11(12):e0167071. PMC: 5132002. DOI: 10.1371/journal.pone.0167071. View

Salvatore S, Troxell M, Hecox D, Sperling K, Seshan S . Smoking-related glomerulopathy: expanding the morphologic spectrum. Am J Nephrol. 2015; 41(1):66-72. DOI: 10.1159/000371727. View

Jin A, Koh W, Chow K, Yuan J, Jafar T . Smoking and risk of kidney failure in the Singapore Chinese health study. PLoS One. 2013; 8(5):e62962. PMC: 3650019. DOI: 10.1371/journal.pone.0062962. View

Park S, Chun J, Han K, Soh H, Kang E, Lee H . Dose-response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study. J Gastroenterol. 2019; 54(10):881-890. DOI: 10.1007/s00535-019-01589-3. View

10.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B . Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888):260-72. DOI: 10.1016/S0140-6736(13)60687-X. View

11.

Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y . Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017; 32(3):475-487. DOI: 10.1093/ndt/gfw452. View

12.

Carter B, Abnet C, Feskanich D, Freedman N, Hartge P, Lewis C . Smoking and mortality--beyond established causes. N Engl J Med. 2015; 372(7):631-40. DOI: 10.1056/NEJMsa1407211. View

13.

Staplin N, Haynes R, Herrington W, Reith C, Cass A, Fellstrom B . Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016; 68(3):371-80. PMC: 4996629. DOI: 10.1053/j.ajkd.2016.02.052. View

14.

Seo M, Lee W, Kim S, Kang J, Kang J, Kim K . 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea. J Obes Metab Syndr. 2019; 28(1):40-45. PMC: 6484940. DOI: 10.7570/jomes.2019.28.1.40. View

15.

Bash L, Astor B, Coresh J . Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009; 55(1):31-41. DOI: 10.1053/j.ajkd.2009.09.006. View

16.

Benck U, Clorius J, Zuna I, Ritz E . Renal hemodynamic changes during smoking: effects of adrenoreceptor blockade. Eur J Clin Invest. 1999; 29(12):1010-8. DOI: 10.1046/j.1365-2362.1999.00566.x. View

17.

Chase H, Garg S, Marshall G, Berg C, Harris S, Jackson W . Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA. 1991; 265(5):614-7. View

18.

Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T . Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2006; 71(2):159-66. DOI: 10.1038/sj.ki.5002017. View

19.

Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K . Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up. PLoS One. 2015; 10(8):e0135052. PMC: 4555650. DOI: 10.1371/journal.pone.0135052. View

20.

Choi H, Kim H, Han K, Jung J, Kim C, Bae E . Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea. Clin Exp Nephrol. 2019; 23(12):1391-1397. DOI: 10.1007/s10157-019-01779-6. View